179 related articles for article (PubMed ID: 11377688)
1. Slowly progressive systemic mastocytosis with high mast-cell burden and no evidence of a non-mast-cell hematologic disorder: an example of a smoldering case?
Akin C; Scott LM; Metcalfe DD
Leuk Res; 2001 Jul; 25(7):635-8. PubMed ID: 11377688
[TBL] [Abstract][Full Text] [Related]
2. A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
Jordan JH; Fritsche-Polanz R; Sperr WR; Mitterbauer G; Födinger M; Schernthaner GH; Christian Bankl H; Gebhart W; Chott A; Lechner K; Valent P
Leuk Res; 2001 Jul; 25(7):627-34. PubMed ID: 11377687
[TBL] [Abstract][Full Text] [Related]
3. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
[TBL] [Abstract][Full Text] [Related]
5. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.
Escribano L; Díaz-Agustín B; Bellas C; Navalón R; Nuñez R; Sperr WR; Schernthaner GH; Valent P; Orfao A
Leuk Res; 2001 Jul; 25(7):563-70. PubMed ID: 11377681
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukaemia with t(8;21) associated with "occult" mastocytosis. Report of an unusual case and review of the literature.
Bernd HW; Sotlar K; Lorenzen J; Osieka R; Fabry U; Valent P; Horny HP
J Clin Pathol; 2004 Mar; 57(3):324-8. PubMed ID: 14990611
[TBL] [Abstract][Full Text] [Related]
7. Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.
Noack F; Sotlar K; Notter M; Thiel E; Valent P; Horny HP
Leuk Lymphoma; 2004 Nov; 45(11):2295-302. PubMed ID: 15512820
[TBL] [Abstract][Full Text] [Related]
8. Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology.
Akin C; Schwartz LB; Kitoh T; Obayashi H; Worobec AS; Scott LM; Metcalfe DD
Blood; 2000 Aug; 96(4):1267-73. PubMed ID: 10942367
[TBL] [Abstract][Full Text] [Related]
9. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
10. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
[TBL] [Abstract][Full Text] [Related]
11. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I
Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool.
Sánchez-Muñoz L; Teodosio C; Morgado JM; Perbellini O; Mayado A; Alvarez-Twose I; Matito A; Jara-Acevedo M; García-Montero AC; Orfao A; Escribano L
Immunol Allergy Clin North Am; 2014 May; 34(2):297-313. PubMed ID: 24745675
[TBL] [Abstract][Full Text] [Related]
13. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
Divekar R; Butterfield J
Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry.
Li CY
Leuk Res; 2001 Jul; 25(7):537-41. PubMed ID: 11377678
[TBL] [Abstract][Full Text] [Related]
15. Mastocytosis.
Brockow K; Metcalfe DD
Chem Immunol Allergy; 2010; 95():110-124. PubMed ID: 20519885
[TBL] [Abstract][Full Text] [Related]
16. Mastocytosis: immunophenotypical features of the transformed mast cells are unique among hematopoietic cells.
Horny HP; Sotlar K; Valent P
Immunol Allergy Clin North Am; 2014 May; 34(2):315-21. PubMed ID: 24745676
[TBL] [Abstract][Full Text] [Related]
17. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
Lawrence JB; Friedman BS; Travis WD; Chinchilli VM; Metcalfe DD; Gralnick HR
Am J Med; 1991 Dec; 91(6):612-24. PubMed ID: 1750431
[TBL] [Abstract][Full Text] [Related]
18. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-1992. A 57-year-old man with a 20-year history of episodic headache, Flushing, hypotension, and occasional syncope.
N Engl J Med; 1992 Feb; 326(7):472-81. PubMed ID: 1732774
[No Abstract] [Full Text] [Related]
19. In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells.
Soucie E; Hanssens K; Mercher T; Georgin-Lavialle S; Damaj G; Livideanu C; Chandesris MO; Acin Y; Létard S; de Sepulveda P; Hermine O; Bernard OA; Dubreuil P
Blood; 2012 Dec; 120(24):4846-9. PubMed ID: 23074272
[TBL] [Abstract][Full Text] [Related]
20. The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid.
Ridell B; Olafsson JH; Roupe G; Swolin B; Granerus G; Rödjer S; Enerbäck L
Arch Dermatol; 1986 Apr; 122(4):422-7. PubMed ID: 3954410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]